Table 2.
Participant number | Medication | Dosage | Frequency |
---|---|---|---|
P01 | Levodopa/carbidopa | 25–100 mg | 3x/day |
P02 | De Novo | ||
P03 | Pramipexole | 1 mg | 3x/day |
Rasagiline | 1 mg | 1x/day | |
Levodopa/carbidopa | 50–200 mg | 3x/day | |
P04 | De Novo | ||
P05 | Pramipexole | 1.5 mg | 3x/day |
Selegiline | 5 mg | 2x/day | |
P06 | Rasagiline | 1 mg | 1x/day |
Amantadine | 100 mg | 2x/day | |
P07 | De Novo | ||
P08 | Rasagiline | 1 mg | 1x/day |
Trihexyphenidyl | 4 to 6 mg | 1x/day | |
P09 | Levodopa/carbidopa | 150 mg | 3x/day |
P10 | Pramipexole | 0.75 mg | 3x/day |
Rasagiline | 1 mg | 1x/day | |
P11 | Pramipexole | 1.5 mg | 3x/day |
Rasagiline | 1 mg | 1x/day | |
P12 | Levodopa/carbidopa | 25–100 mg | 4x/day |
P13 | Levodopa/carbidopa | 25–100 mg | 3x/day |
Rasagiline | 0.5 mg | 1x/day | |
P14 | Pramipexole | 0.5 mg | 3x/day |
P15 | Pramipexole | 1.5 mg | 3x/day |
Selegiline | 5 mg | 2x/day | |
Trihexyphenidyl | 2 mg | 3x/day |